22nd Century Group Has Received A Notice Of Allowance For Its U.S. Patent Application 17/785,153 Titled "GENETIC APPROACH FOR ACHIEVING ULTRA LOW NICOTINE CONTENT IN TOBACCO"
Portfolio Pulse from Benzinga Newsdesk
22nd Century Group has received a Notice of Allowance for its U.S. Patent Application 17/785,153 titled 'GENETIC APPROACH FOR ACHIEVING ULTRA LOW NICOTINE CONTENT IN TOBACCO'.
August 14, 2024 | 5:07 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
22nd Century Group has received a Notice of Allowance for its U.S. Patent Application 17/785,153, which focuses on a genetic approach for achieving ultra-low nicotine content in tobacco.
The Notice of Allowance for the patent application indicates that the patent will likely be granted, which could enhance 22nd Century Group's competitive position in the market for low-nicotine tobacco products. This development is likely to be viewed positively by investors, potentially driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100